SCHEMBL3346538

SCHEMBL3346538

Clc1ccc(CN2CCC3(CC2)CNCCO3)cc1

nearest known ligand 0.50

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 12/20 0.50
CHRM3 P20309 12/20 0.50
SLC6A2 P23975 3/20 0.47
SLC6A4 P31645 3/20 0.47
SLC6A3 Q01959 3/20 0.47
KCNH2 Q12809 1/20 0.46
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
SIGMAR1 Q99720 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1975664 0.87 SLC6A2 (0.60) SLC6A2SLC6A4SLC6A3ALDH1A1SIGMAR1
SCHEMBL13115964 0.80 TSHR (0.56) CHRM2CHRM3SLC6A2SLC6A4SLC6A3
SCHEMBL2141459 0.76 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL1246679 0.75 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL17318884 0.74 LMNA (0.59) CHRM2SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL2142306 0.73 SLC6A2 (0.43) SLC6A2SLC6A4SLC6A3
SCHEMBL25787415 0.72 TSHR (0.45) SLC6A2SLC6A4SLC6A3KDM4E
SCHEMBL17611714 0.72 CYP2D6 (0.49) CHRM2SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL20455758 0.71 CYP2D6 (0.64) ALDH1A1
SCHEMBL208118 0.71 SIGMAR1 (0.68) CHRM2KDM4EALDH1A1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010067102-A1 DIAZASPIRO [5.5] UNDECANE DERIVATIVES AND RELATED COMPOUNDS AS MUSCARINIC-RECEPTOR ANTAGONISTS AND BETA-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY DISORDERS ASTRAZENECA AB (SE) 2010-06-17 WO disclosed
WO-2010067102-A1 DIAZASPIRO [5.5] UNDECANE DERIVATIVES AND RELATED COMPOUNDS AS MUSCARINIC-RECEPTOR ANTAGONISTS AND BETA-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY DISORDERS ASTRAZENECA AB (SE) 2010-06-17 WO disclosed